scispace - formally typeset
Z

Zhen Zhao

Researcher at University of Southern California

Publications -  80
Citations -  8002

Zhen Zhao is an academic researcher from University of Southern California. The author has contributed to research in topics: Blood–brain barrier & Pericyte. The author has an hindex of 32, co-authored 69 publications receiving 5368 citations. Previous affiliations of Zhen Zhao include Zilkha Neurogenetic Institute & University of Rochester.

Papers
More filters
Journal ArticleDOI

Establishment and Dysfunction of the Blood-Brain Barrier

TL;DR: The mechanisms regulating the formation and maintenance of the BBB and functions of BBB-associated cell types are examined and the growing evidence associating BBB breakdown with the pathogenesis of inherited monogenic neurological disorders and complex multifactorial diseases, including Alzheimer's disease is discussed.
Journal ArticleDOI

Blood-Brain Barrier: From Physiology to Disease and Back

TL;DR: This review examines molecular and cellular mechanisms underlying the establishment of the blood-brain barrier, and examines how BBB dysfunction relates to neurological deficits and other pathologies in the majority of sporadic AD, PD, and ALS cases, multiple sclerosis, other neurodegenerative disorders, and acute CNS disorders.
Journal ArticleDOI

Pericyte loss influences Alzheimer-like neurodegeneration in mice.

TL;DR: It is shown that in mice overexpressing Aβ-precursor protein-overexpressing mice, pericyte loss elevates brain Aβ40 and Aβ42 levels and accelerates amyloid angiopathy and cerebral β-amyloidosis by diminishing clearance from brain interstitial fluid prior to Aβ deposition.
Journal ArticleDOI

Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.

TL;DR: It is suggested that APOE4 leads to accelerated pericyte loss and enhanced activation of LRP1-dependent CypA–MMP-9 BBB-degrading pathway in pericytes and endothelial cells, which can mediate a greater BBB damage in AD APOE2 and APOE3 carriers.